Uranium ETF Rebounds 4% as Physical Prices Diverge From Battered Reactor Stocks
The gap between an 18-year-high uranium contract price and collapsing advanced-reactor equity valuations has investors reassessing where value sits in nuclear energy.
The URA uranium exchange-traded fund climbed 4.17% by mid-afternoon on Tuesday (2026-08-25), a rebound that follows selling across nuclear names including NuScale Power and Oklo, which each fell around 5%, and Centrus Energy, which shed 6%, on August 20 (2026-08-20).7
The long-term uranium contract price ended June at $94 per pound — its highest in 18 years — while uranium mining equities fell 3.9% over the first half of 2026 and junior uranium miners lost 7.4%, according to Sprott Asset Management. In June alone, the two equity indexes dropped 14.4% and 17.5%, respectively.5
Sprott's Jacob White, ETF product manager, wrote that "a rising long-term price shows that the market remains tight, even if equity markets don't reflect it." The firm holds 81.4 million pounds of uranium oxide with a net asset value of about $7.1 billion and has called the equity selloff a buying opportunity, arguing that constrained supply goes largely unpriced in the mining stocks.5
The pain has been deepest at the pre-commercial end of the market. Oklo and NuScale Power were down 73% and 83%, respectively, from their 52-week highs as of July 8 (2026-07-08), capping a sharp reversal after strong 2025 runs. Both stocks were down 27% and 30% from the start of 2026 through that same date. Cameco, the established Canadian miner, had gained 7% year-to-date by July 8 (2026-07-08) yet sat 27% below its February peak.1
Uranium Energy Corp. held up better than the pre-commercial reactor developers over the same stretch. The distinction reflects where the pressure is concentrated: uranium miners and fuel suppliers can benefit from tighter nuclear-fuel markets even when small modular reactor start-ups face higher financing costs and longer development timelines.7
Truist analyst Christopher Souther has described the market's demand precisely. Investors are increasingly looking for evidence that these companies can build, license, and deploy reactors — not just propose them. Souther noted that first-of-a-kind projects are moving from concept to execution, but that shift has not yet been enough to defend equity valuations.2
The underlying demand case hasn't softened. The EIA expects U.S. electricity use to reach a record 4,269 billion kilowatt-hours in 2026, rising to 4,399 billion kilowatt-hours in 2027. Nuclear provides 47% of the country's zero-emissions electricity, more than wind and solar combined as of 2023.4,3
Policy support has continued to build. The U.S. Department of Energy announced $17.5 billion in conditional loans in June to fund long-lead items for up to 10 new reactors. The Trump administration's target to quadruple U.S. nuclear capacity from roughly 100 gigawatts adds political momentum behind that commitment.5,4
Cameco is positioning to lock in contracted revenue ahead of any new supply. It has committed to delivering an average of 28 million pounds of uranium per year over the next five years. In March, Cameco signed a $2.6 billion deal with India's Department of Atomic Energy to supply 22 million pounds of uranium ore concentrate through 2035.3
The starkest contrast with pre-commercial distress sits in the operating fleet. Constellation holds 22 gigawatts of nuclear capacity across 14 generating stations and supplies around 10% of U.S. clean electricity. Its average capacity factor runs near 94%, according to Motley Fool reporting from August 5 (2026-08-05), and analysts project earnings-per-share growth of 13% in 2027 and nearly 29% in 2028.6
The DOE's $17.5 billion in conditional loan commitments have not funded a single draw. The first advanced reactor developer to move a licensed project to a funded construction start will tell the market far more than any further policy announcement.5